Impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: Insights from the POLISH STEMI registry

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 516-520

  De Luca, Giuseppe ^a   Małek, Lukasz A ^b   Maciejewski, Paweł ^c   Wasek, Wojciech ^c   Niewada, Maciej ^d   Kamiński, Bogumił ^e   wiecki, Janusz Drze ^f   Kośmider, Maciej ^g   Kubica, Jacek ^h   Ruzyłło, Witold ^b   Peruga, Jan Z ⁱ   Dudek, Dariusz ^j   Opolski, Grzegorz ^d   Dobrzycki, Sławomir ^k   Gil, Robert J ^l   Witkowski, Adam ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b INSTITUTE OF CARDIOLOGY   (Poland)

^c GROCHOWSKI HOSPITAL   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

^e WARSAW SCHOOL OF ECONOMICS   (Poland)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g Medical University   (Poland)

^h NICOLAUS COPERNICUS UNIVERSITY   (Poland)

ⁱ Department of Haemodynamics   (Poland)

^j JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^k MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^l Central Hospital of the Internal Affairs and Administration Ministry   (Poland)

more..

Author keywords

Diabetes; Mortality; Primary angioplasty; STEMI

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN;

ADULT; AGED; AGING; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; EPICARDIUM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERLIPIDEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REGISTER; RISK FACTOR; SEX DIFFERENCE; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; SURVIVAL RATE; TREATMENT RESPONSE;

AGE FACTORS; AGED; ANGIOPLASTY; COHORT STUDIES; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLAND; REGISTRIES; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 77953233397     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.12.012     Document Type: Article

References (36)

1. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008;117(January (2)):296-329.
2. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993, 328:673-679.
3. Zijlstra F., Hoorntje J.C.A., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999, 341:1413-1419.
4. Suryapranata H., van't Hof A., Hoorntje J.C.A., de Boer M.J., Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998, 97:2502-2505.
5. Stone G.W., et al. Comparison of angioplasty with stenting with or without abciximab, in acute myocardial infarction. N Engl J Med 2002, 346:957-966.
6. Capes S.E., Hunt D., Malmberg K., Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778.
7. Bolk J., van der Ploeg T., Cornel J.H., Arnold A.E., Sepers J., Umans V.A. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001, 79:207-214.
8. Porter A., Assali A.R., Zahalka A., et al. Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus. Am Heart J 2008, 155(February (2)):284-289. [Epub 2007 Nov 26].
9. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial Blush Grade. Circulation 1998, 97:2302-2306. on the behalf of the Zwolle Myocardial Infarction Study Group.
10. van't Hof A.W.J., Liem A., de Boer M.J., Zijlstra F. Clinical value of 12-lead elettrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997, 350:615-619.
11. Gibson C.M., Cannon C.P., Murphy S.A., et al. The relationship of the TIMI myocardial perfusion grade to mortality after thrombolytic administration. Circulation 2000, 101:125-130.
12. Marso S.P., Miller T., Rutherford B.D., et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol 2007, 100(July (2)):206-210. [Epub 2007 Jun 4].
13. Ishihara M., Kagawa E., Inoue I., et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 2007, 99(June (12)):1674-1679.
14. Timmer J.R., van der Horst I.C., de Luca G., et al. Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus. Am J Cardiol 2005, 95(June (11)):1375-1377.
15. Marfella R., Esposito K., Giunta R., et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 2000, 101:2247-2251.
16. Booth G., Stalker T.J., Lefer A.M., Scalia R. Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab 2001, 280:E848-E856.
17. Hokama J.Y., Ritter L.S., Davis-Gorman G., Cimetta A.D., Copeland J.G., McDonagh P.F. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia. J Diabetes Complicat 2000, 14:96-107.
18. Engler R.L., Dahlgren M.D., Morris D.D., Peterson M.A., Schmid-Schonbein G.W. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986, 251:H314-H323.
19. Shechter M., Merz C.N., Paul-Labrador M.J., Kaul S. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 2000, 35:300-307.
20. Sakuma T., Leong-Poi H., Fisher N.G., Goodman N.C., Kaul S. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. J Am Soc Echocardiogr 2003, 16:15-21.
21. Nitenberg, Valensi P., Sachs R., Dali M., Aptecar E., Attali J.-R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993, 42:1017-1025.
22. Nahser P.J., Brown R.E., Oskarsson H., Winniford M.D., Rossen J.D. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995, 91:635-640.
23. Ishihara M., Inoue I., Kawagoe T., et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 2001, 38:1007-1011.
24. Iwakura K., Ito H., Ikushima M., et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003, 41:1-7.
25. Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997, 30:171-179.
26. Timmer J.R., Ottervanger J.P., de Boer M.J., et al. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs. Thrombolysis-2 trial. Arch Intern Med 2007, 167:1353-1359.
27. Prasad A., Stone G.W., Stuckey T.D., et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2005, 45:508-514.
28. De Luca G., Gibson C.M., Bellandi F., et al. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. Atherosclerosis 2009, 207:181-185.
29. Zellweger M.J., Hachamovitch R., Kang X., et al. Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease. J Nucl Cardiol 2009, 16:193-200.
30. De Luca G., Suryapranata H., Marino P. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status. Prog Cardiovasc Dis 2008, 50:352-382.
31. Neumann F.J., Blasini R., Schmitt C., et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998, 98:2695-2701.
32. De Luca G., Suryapranata H., Stone G.W., et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005, 293:1759-1765.
33. De Luca G., Suryapranata H., Stone G.W., Antoniucci D., Neumann F.J., Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J 2007, 153:343-353.
34. Vlaar P.J., Svilaas T., van der Horst I.C., et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 2008, 371:1915-1920.
35. De Luca G., Suryapranata H., Ottervanger J.P., Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004, 109:1223-1225.
36. Suryapranata H., De Luca G., van't Hof A.W., et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart 2005, 91:641-645.